Skip to content
AnalystLens
Back to BBIOBalance Sheet

BridgeBio Pharma Shares Outstanding 2018-2026 | BBIO

Annual FY2018–FY2025 · quarterly through Q3 FY2026

Latest annual · FY2025

194.8M

+2.5%YoY vs FY2024Source: 10-KFY2025

From 92.1M in FY2018 to 194.8M in FY2025: 2.1× in 7 years.

By quarter▲▼ vs a year before
Fiscal yearQ1Q2Q3Q4
FY26196M+3.1%195M+2.2%196M+1.8%Not reported
FY25190M+1.4%191M+1.7%193M+1.9%195M+2.5%
FY24187M+16.6%188M+16.5%189M+8.5%190M+8.5%
FY23160M+8.6%161M+8.9%174M+16.6%175M+16.2%
FY22148M−1.0%148M−0.9%149M+1.5%151M+2.2%

Shaded by size: darkest is the largest quarter shown; ringed is the latest reported; a dash marks a quarter with no separate figure. Each quarter sits by its period-end date.

Key Statistics

Trend DirectionGrowing
CAGR

+9.7%

FY2020
122.8M
FY2025
194.8M

5 years selected · on the chart

Shares Outstanding History

Year-over-year comparison from 10-K annual reports

  1. 194.8M
YoY changeLargest recent move+34.3%in FY19Latest +2.5%

Shares Outstanding, period by period

PeriodValueChangeSource
FY2025194.8M+2.5%10-K
FY2024190.0M+8.5%10-K
FY2023175.1M+16.2%10-K
FY2022150.6M+2.2%10-K
FY2021147.3M+19.9%10-K
FY2020122.8M−0.7%10-K
FY2019123.7M+34.3%10-K
FY201892.1M—10-K

What is shares outstanding?

Shares outstanding is the total number of common shares currently held by all shareholders, including restricted shares.

What is BridgeBio Pharma's current shares outstanding?

BridgeBio Pharma (BBIO) annual shares outstanding for 2025 was 194.8M, a 2.49% increase from 2024. BridgeBio Pharma shares outstanding for the quarter ending September 30, 2026 was 196.0M.

What was BridgeBio Pharma's shares outstanding in 2024?

BridgeBio Pharma annual shares outstanding for 2024 was 190.0M, a 8.55% increase from 2023.

What was BridgeBio Pharma's shares outstanding in 2023?

BridgeBio Pharma annual shares outstanding for 2023 was 175.1M, a 16.24% increase from 2022.

What is BridgeBio Pharma's 5-year shares outstanding CAGR?

BridgeBio Pharma shares outstanding grew at a compound annual growth rate (CAGR) of 9.66% from FY2020 to FY2025, going from 122.8M to 194.8M over 5 years.

Company
BridgeBio Pharma
Ticker
BBIO
Sector
Healthcare
Industry
Pharmaceutical Preparations